Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer.
Taking the in mineral appurtenance selenium doesn't up the likelihood of lung cancer recurrence, a new study reveals. Lead author Dr Daniel D Karp, a professor in the bailiwick of thoracic head and neck medical oncology at the University of Texas MD Anderson Cancer Center, is scheduled to make known the finding Saturday at the American Society of Clinical Oncology annual meeting, in Chicago buy progestelle in nz. "Several epidemiological and beastlike studies have long-suggested a relation between deficiency of selenium and cancer development," said Karp in a copy release.

So "Interest and research escalated in the late 1990s after a skin cancer and selenium study, published in 1996, found no better against the skin cancer, but did suggest an approximate 30 percent reduction of prostate and lung cancers vitoviga.top. Our lung cancer study and another major study for the prevention of prostate cancer evolved from that finding".

But the strange study found that among more than 1,500 stage 1 (early) non-small apartment lung cancer patients who had survived their initial bout with the disease, selenium offered no safe keeping against recurrence or the onset of a new cancer or second primary cancer. The patients were tracked from 2000 to 2009, after all had undergone surgery to obliterate their initial tumors and remained cancer-free for a least of six months post-treatment.

Half the patients were placed on a regimen of 200 micrograms of selenium, while the other half took a placebo. Those in the placebo union had better survival rates five years later than those taking the annexe - an observation that led the research team to halt the cramming earlier than planned.

While 78 percent taking the placebo stayed alive over that time frame, the chew out was just 72 percent among the selenium group. And while 1,4 percent of the placebo squad developed a second primary tumor within a year, that figure rose to 1,9 percent middle the selenium group, the researchers said neuqun. Some benefit of selenium was observed in a small gather of patients who had never smoked, but the study authors said the group was too small to render the finding meaningful.